124 related articles for article (PubMed ID: 14676083)
1. Adjuvant high-dose interferon therapy for high-risk melanoma.
Ready N; Weinstock MA
Arch Dermatol; 2003 Dec; 139(12):1635-7. PubMed ID: 14676083
[No Abstract] [Full Text] [Related]
2. Noninterferon-based adjuvant therapy for high-risk melanoma.
Spitler LE
Expert Rev Anticancer Ther; 2002 Oct; 2(5):547-62. PubMed ID: 12382523
[TBL] [Abstract][Full Text] [Related]
3. [Adjuvant interferon treatment of melanoma].
Török L
Magy Onkol; 2003; 47(1):105-7. PubMed ID: 12704462
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant interferon therapy for melanoma: high-dose, low-dose, no dose, which dose?
Schuchter LM
J Clin Oncol; 2004 Jan; 22(1):7-10. PubMed ID: 14665612
[No Abstract] [Full Text] [Related]
5. Adjuvant interferon in melanoma - a resurrection?
Middleton MR; Thatcher N
Br J Cancer; 2001 May; 84(9):1141-2. PubMed ID: 11336461
[No Abstract] [Full Text] [Related]
6. Present status and future prospects for adjuvant therapy of melanoma: time to build upon the foundation of high-dose interferon alfa-2b.
Moschos SJ; Kirkwood JM; Konstantinopoulos PA
J Clin Oncol; 2004 Jan; 22(1):11-4. PubMed ID: 14665613
[No Abstract] [Full Text] [Related]
7. Adjuvant interferon therapy for melanoma.
Hancock B; Wheatley K; Ives N; Gore M
J Clin Oncol; 2005 Apr; 23(10):2431; author reply 2431-2. PubMed ID: 15800339
[No Abstract] [Full Text] [Related]
8. Adjuvant high-dose interferon-alpha therapy for high-risk melanoma.
Kirkwood JM; Tarhini AA
Forum (Genova); 2003; 13(2):127-40; quiz 187-8. PubMed ID: 14732880
[TBL] [Abstract][Full Text] [Related]
9. How melanoma is treated in real life.
Dummer R; Schadendorf D
Arch Dermatol; 2008 May; 144(5):664-5. PubMed ID: 18490596
[No Abstract] [Full Text] [Related]
10. Adjuvant therapy for malignant melanoma.
Stoutenburg JP; Schrope B; Kaufman HL
Expert Rev Anticancer Ther; 2004 Oct; 4(5):823-35. PubMed ID: 15485316
[TBL] [Abstract][Full Text] [Related]
11. Building upon the standard of care in adjuvant therapy of high-risk melanoma.
Kirkwood JM
J Clin Oncol; 2005 Dec; 23(34):8559-63. PubMed ID: 16260699
[No Abstract] [Full Text] [Related]
12. High-risk surgically resected pediatric melanoma and adjuvant interferon therapy.
Chao MM; Schwartz JL; Wechsler DS; Thornburg CD; Griffith KA; Williams JA
Pediatr Blood Cancer; 2005 May; 44(5):441-8. PubMed ID: 15468307
[TBL] [Abstract][Full Text] [Related]
13. Diverging opinions on interferon therapy for melanoma.
Winn RJ
J Natl Compr Canc Netw; 2004 Jan; 2(1):1. PubMed ID: 19777689
[No Abstract] [Full Text] [Related]
14. [Adjuvant interferon therapy in malignant melanoma].
Mohr P
J Dtsch Dermatol Ges; 2007 Jun; 5(6):543-5. PubMed ID: 17537052
[No Abstract] [Full Text] [Related]
15. Interleukin-2 for the treatment of melanoma.
Tarhini AA; Agarwala SS
Curr Opin Investig Drugs; 2005 Dec; 6(12):1234-9. PubMed ID: 16370388
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant therapy for cutaneous melanoma.
Nathan FE; Mastrangelo MJ
Semin Oncol; 1995 Dec; 22(6):647-61. PubMed ID: 8539640
[No Abstract] [Full Text] [Related]
17. Evidence-based and interdisciplinary consensus-based German guidelines: systemic medical treatment of melanoma in the adjuvant and palliative setting.
Garbe C; Hauschild A; Volkenandt M; Schadendorf D; Stolz W; Reinhold U; Kortmann RD; Kettelhack C; Frerich B; Keilholz U; Dummer R; Sebastian G; Tilgen W; Schuler G; Mackensen A; Kaufmann R
Melanoma Res; 2008 Apr; 18(2):152-60. PubMed ID: 18337653
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant treatment of malignant melanoma: where are we?
Ascierto PA; Scala S; Ottaiano A; Simeone E; de Michele I; Palmieri G; Castello G
Crit Rev Oncol Hematol; 2006 Jan; 57(1):45-52. PubMed ID: 15990330
[TBL] [Abstract][Full Text] [Related]
19. Prospective, randomized, multicenter, double-blind placebo-controlled trial comparing adjuvant interferon alfa and isotretinoin with interferon alfa alone in stage IIA and IIB melanoma: European Cooperative Adjuvant Melanoma Treatment Study Group.
Richtig E; Soyer HP; Posch M; Mossbacher U; Bauer P; Teban L; Svolba G; Wolf IH; Fritsch P; Zelger B; Volc-Platzer B; Gebhart W; Mischer P; Steiner A; Pachinger W; Hintner H; Gschnait F; Rappersberger K; Pilarski P; Pehamberger H;
J Clin Oncol; 2005 Dec; 23(34):8655-63. PubMed ID: 16260701
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant interferon: recommit or move on?
Kudchadkar R; Sondak V
Lancet Oncol; 2011 Feb; 12(2):112-3. PubMed ID: 21256808
[No Abstract] [Full Text] [Related]
[Next] [New Search]
